Name: Biogen Inc. (NASDAQ:BIIB) | Balance Sheet: Assets (Quarterly)
Creator: Stock Analysis on Net

Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Assets: Selected Items

Download chart

Current Assets: Selected Items

Download chart

Biogen Inc., consolidated balance sheet: assets (quarterly data)

US$ in thousands

	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017
Cash and cash equivalents	3,675,600)	2,646,600)	1,749,300)	2,261,400)	1,541,800)	1,742,000)	1,217,500)	1,331,200)	2,224,800)	2,384,900)	2,591,300)	2,913,700)	2,343,900)	1,723,400)	2,243,200)	1,224,600)	2,386,700)	1,250,200)	4,108,000)	1,573,800)	1,548,100)	1,169,500)	924,000)
Marketable securities	1,235,500)	2,151,300)	2,002,400)	1,541,100)	1,413,300)	1,308,800)	1,320,000)	1,278,900)	1,355,000)	1,942,700)	1,269,100)	1,562,200)	2,093,500)	1,228,800)	1,665,800)	2,313,400)	2,041,700)	1,974,000)	1,808,000)	2,115,200)	1,960,200)	1,723,500)	1,956,200)
Accounts receivable, net	1,568,800)	1,567,600)	1,632,000)	1,549,400)	1,723,000)	1,688,000)	1,854,300)	1,913,800)	2,024,900)	2,133,600)	2,092,600)	1,880,500)	1,933,500)	1,959,600)	2,088,900)	1,958,500)	2,017,300)	1,951,000)	1,939,200)	1,787,000)	1,567,500)	1,630,200)	1,501,500)
Due from anti-CD20 therapeutic programs	415,400)	435,900)	389,400)	412,300)	400,000)	422,200)	369,800)	413,500)	527,200)	441,100)	511,600)	590,200)	582,300)	557,500)	527,100)	526,900)	508,400)	481,900)	553,500)	532,600)	518,000)	502,900)	324,500)
Inventory	1,375,000)	1,294,200)	1,215,400)	1,351,500)	1,347,900)	1,254,800)	1,171,800)	1,068,600)	1,027,700)	952,700)	858,800)	804,200)	751,800)	776,700)	770,200)	929,900)	916,600)	931,700)	890,800)	902,700)	1,007,200)	936,500)	921,600)
Assets held for sale	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	683,400)	682,000)	—)	—)	—)	—)	—)	—)	—)	—)
Other current assets	1,495,500)	1,645,300)	927,400)	740,800)	736,300)	767,900)	786,100)	881,100)	683,500)	638,800)	683,800)	631,000)	743,200)	980,400)	965,400)	687,600)	848,300)	843,300)	895,900)	962,000)	967,000)	1,146,100)	1,231,900)
Current assets	9,765,800)	9,740,900)	7,915,900)	7,856,500)	7,162,300)	7,183,700)	6,719,500)	6,887,100)	7,843,100)	8,493,800)	8,007,200)	8,381,800)	8,448,200)	7,909,800)	8,942,600)	7,640,900)	8,719,000)	7,432,100)	10,195,400)	7,873,300)	7,568,000)	7,108,700)	6,859,700)
Marketable securities	860,300)	1,102,900)	1,001,600)	892,000)	968,300)	915,100)	821,900)	772,100)	1,009,800)	922,800)	969,500)	1,408,100)	1,813,900)	1,309,300)	1,372,700)	1,375,900)	1,244,500)	1,160,200)	1,200,200)	3,057,300)	3,062,000)	2,632,700)	2,825,200)
Property, plant and equipment, net	3,266,400)	3,355,100)	3,372,800)	3,416,400)	3,410,700)	3,442,200)	3,438,300)	3,411,500)	3,359,900)	3,330,700)	3,281,600)	3,247,300)	3,138,100)	3,077,500)	3,013,800)	3,601,200)	3,538,900)	3,409,000)	3,334,700)	3,182,400)	2,995,900)	2,827,600)	2,610,900)
Operating lease assets	424,500)	321,100)	359,000)	375,400)	389,100)	402,500)	414,500)	433,300)	434,200)	436,200)	422,000)	427,000)	422,000)	434,400)	447,800)	—)	—)	—)	—)	—)	—)	—)	—)
Intangible assets, net	2,008,900)	2,075,300)	2,150,800)	2,221,300)	2,286,800)	2,385,000)	2,988,100)	3,084,300)	3,323,600)	3,383,800)	3,446,900)	3,527,400)	3,392,400)	3,681,300)	3,056,200)	3,120,000)	3,379,000)	3,661,300)	3,794,500)	3,879,600)	4,019,400)	4,051,300)	4,103,900)
Goodwill	5,741,200)	5,749,600)	5,758,000)	5,761,100)	5,760,500)	5,763,900)	5,763,100)	5,762,100)	5,755,700)	5,751,000)	5,752,000)	5,757,800)	5,746,100)	5,749,200)	5,639,700)	5,706,400)	5,440,100)	5,170,300)	4,907,800)	4,632,500)	4,127,500)	3,870,400)	3,611,700)
Deferred tax asset	1,174,500)	1,235,700)	1,288,800)	1,415,100)	1,810,400)	1,849,900)	1,286,300)	1,369,500)	1,372,900)	1,710,200)	3,109,400)	3,232,100)	3,284,500)	2,820,100)	2,074,400)	2,153,900)	2,160,900)	2,217,900)	2,277,400)	595,900)	—)	—)	—)
Investments and other assets	1,612,600)	1,500,800)	1,767,500)	1,939,500)	2,018,600)	2,528,100)	2,423,000)	2,899,000)	1,834,900)	1,483,300)	1,130,600)	1,252,800)	1,238,800)	1,306,000)	1,898,300)	1,690,600)	1,009,800)	902,100)	380,100)	431,600)	1,300,400)	1,268,300)	1,184,500)
Long-term assets	15,088,400)	15,340,500)	15,698,500)	16,020,800)	16,644,400)	17,286,700)	17,135,200)	17,731,800)	17,091,000)	17,018,000)	18,112,000)	18,852,500)	19,035,800)	18,377,800)	17,502,900)	17,648,000)	16,773,200)	16,520,800)	15,894,700)	15,779,300)	15,505,200)	14,650,300)	14,336,200)
Total assets	24,854,200)	25,081,400)	23,614,400)	23,877,300)	23,806,700)	24,470,400)	23,854,700)	24,618,900)	24,934,100)	25,511,800)	26,119,200)	27,234,300)	27,484,000)	26,287,600)	26,445,500)	25,288,900)	25,492,200)	23,952,900)	26,090,100)	23,652,600)	23,073,200)	21,759,000)	21,195,900)

Total assets exhibited a general upward trajectory from March 2017 through September 2019, peaking at approximately 27.48 billion USD before stabilizing and slightly declining to 24.85 billion USD by September 2022. This movement reflects a strategic shift in asset composition, where current assets grew over the long term while long-term assets experienced a more pronounced contraction in the latter half of the analyzed period.

Liquidity and Current Asset Management: Current assets demonstrated a net increase from 6.86 billion USD in March 2017 to 9.77 billion USD in September 2022. This growth was characterized by substantial volatility in cash and cash equivalents, which reached a peak of 4.11 billion USD in March 2018 and ended the period at 3.68 billion USD. Inventory levels followed a consistent upward trend, rising from 921.6 million USD to 1.38 billion USD, while accounts receivable remained relatively stable, typically fluctuating between 1.5 billion USD and 2.1 billion USD.
Long-term Asset Trends: Long-term assets peaked at 19.04 billion USD in September 2019 before declining to 15.09 billion USD by September 2022. A significant contributor to this decline was the reduction in deferred tax assets, which reached a high of 3.28 billion USD in September 2019 and fell to 1.17 billion USD by the end of the period. Property, plant, and equipment grew steadily from 2.61 billion USD in early 2017 to a peak of 3.60 billion USD in December 2018, subsequently contracting slightly to 3.27 billion USD by September 2022.
Intangibles and Goodwill: A divergent trend is observed between goodwill and net intangible assets. Goodwill increased rapidly from 3.61 billion USD in March 2017 and reached a plateau of approximately 5.74 billion USD from late 2018 through September 2022, indicating an absence of significant new acquisitions or impairment charges during that window. In contrast, net intangible assets showed a steady decline, falling from 4.10 billion USD in March 2017 to 2.01 billion USD in September 2022, which is consistent with the routine amortization of intangible assets.
Investment and Other Asset Shifts: Long-term marketable securities experienced a notable decline from initial levels of 2.83 billion USD in March 2017 to a range between 860 million USD and 1.10 billion USD in the final years. Meanwhile, investments and other assets exhibited an overall increase from 1.18 billion USD in March 2017 to 1.61 billion USD in September 2022, despite intermittent volatility.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?

Biogen Inc. (NASDAQ:BIIB)

Balance Sheet: AssetsQuarterly Data

Assets: Selected Items

Current Assets: Selected Items

Balance Sheet: Assets
Quarterly Data